venous thromboembolism
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with venous thrombotic diseases (including deep vein thrombosis, pulmonary embolism, chronic thromboembolic pulmonary hypertension) with contrast CT, angiography examination, limb vein echo 2.There is consent to written participation in this clinical study 3.The age at consent acquisition is over 20 years old
Exclusion criteria
Exclusion criteria: 1.Patients who can not obtain consent from this clinical study 2.Patient with past history of autoimmune disease, patient taking steroid 3.atients with a history of bowel disease and patients after intestinal surgery (excluding appendicitis resection) 4.Patients with active infections, patients receiving antibiotics 5.Patient with cancer or within 5 years after cancer treatment 6.Patients with high frailty 7.Pregnant 8.Other patients who are judged inappropriate by researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composition of intestinal bacterial flora and LPS production | — |
Countries
Japan
Contacts
Kobe University Hospital Cardiology